Table 2 miRNAs as prognostic factors and the associated targets and survival status in pancreatic cancer
From: MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators
| miRNA | Expression in Pancreatic Cancer compared to normal tissue | Survival Status | Targets | Reference |
|---|---|---|---|---|
| -10b | Upregulated | Poor Survival | TIP30 | [94, 95] |
| −21 | Upregulated | Worse Survival | PTEN, PDCD4, IL-6R,CDK6 | [85,86,87] |
| -34a | Upregulated | Better Survival | NOTCH, BCL2, CDK6 | [96,97,98] |
| −155 | Upregulated | Poor Survival | TP53INP | [99, 100] |
| -let-7 Family | Downregulated | Poor Survival | KRAS, HRAS, TRIM71 | [101, 102] |
| −200 Family | Downregulated | Better Survival | E-cadherin, ZEB | [91, 96, 103] |
| −216 | Downregulated | Poor Survival | ROCK1 | [104, 105] |
